9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more
Zymeworks, a early-stage biotech developing bispecific antibodies that target HER2 tumors, raised $59 million by offering 4.5 million shares at $13, the low end of the range of $13 to $16. Zymeworks plans to list on the NYSE under the symbol ZYME. Citi,...read more
A whopping eight deals are on the calendar for the week ahead after a flurry of launches hit Monday. The month's 11 IPOs already make it the most active year-to-date, but if all eight April deals on ...read more
IPOs are multiplying like rabbits after the market's long Easter weekend; seven companies filed terms on Monday to price during the final week of April. The month's 10 IPOs already make it the most active year-to-date, but if all eight deals on ...read more
US IPO Weekly Recap: Floor & Décor pops 53%, Carvana skids 26%
9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more
Zymeworks prices IPO at $13, the low end of the range
Zymeworks, a early-stage biotech developing bispecific antibodies that target HER2 tumors, raised $59 million by offering 4.5 million shares at $13, the low end of the range of $13 to $16. Zymeworks plans to list on the NYSE under the symbol ZYME. Citi,...read more
US IPO Week Ahead: Cloudera leads pack of 8 deals
A whopping eight deals are on the calendar for the week ahead after a flurry of launches hit Monday. The month's 11 IPOs already make it the most active year-to-date, but if all eight April deals on ...read more
7 US IPOs launch to close out an active April
IPOs are multiplying like rabbits after the market's long Easter weekend; seven companies filed terms on Monday to price during the final week of April. The month's 10 IPOs already make it the most active year-to-date, but if all eight deals on ...read more